Statins: underused by those who would benefit.
作者信息
Hulley S B, Grady D, Browner W S
机构信息
Department of Epidemiology, Biostatistics, and Medicine, University of
出版信息
BMJ. 2000 Oct 21;321(7267):971-2. doi: 10.1136/bmj.321.7267.971.
Abstract
摘要
相似文献
1
Statins: underused by those who would benefit.
BMJ. 2000 Oct 21;321(7267):971-2. doi: 10.1136/bmj.321.7267.971.
2
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Am J Cardiol. 1998 Feb 26;81(4A):1B-6B. doi: 10.1016/s0002-9149(98)00030-7.
3
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
4
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
5
[Can the action of statins reveal etiology of coronary diseases?].
Lakartidningen. 2001 Oct 17;98(42):4566-7.
6
Statins and coronary heart disease.
Lancet. 1996 Jul 6;348(9019):57. doi: 10.1016/s0140-6736(05)64379-6.
7
What kinds of studies should be required to probe efficacy and safety of drugs in special populations?
Am J Cardiol. 1998 Apr 23;81(8A):84F-87F.
8
Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.
Drug Saf. 1996 Jan;14(1):11-24. doi: 10.2165/00002018-199614010-00003.
9
Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals.
Arch Dermatol. 1996 Oct;132(10):1254. doi: 10.1001/archderm.1996.03890340120028.
10
Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men.
Biol Psychiatry. 1994 Apr 15;35(8):575-7. doi: 10.1016/0006-3223(94)90107-4.
引用本文的文献
1
Improvement of Platelet Respiration by Cell-Permeable Succinate in Diabetic Patients Treated with Statins.
Life (Basel). 2021 Mar 28;11(4):288. doi: 10.3390/life11040288.
2
Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
J Clin Med. 2021 Feb 22;10(4):886. doi: 10.3390/jcm10040886.
3
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
J Am Heart Assoc. 2019 Oct;8(19):e013229. doi: 10.1161/JAHA.119.013229. Epub 2019 Sep 26.
4
Prevention of cardiovascular events in elderly people.
Drugs Aging. 2005;22(10):859-76. doi: 10.2165/00002512-200522100-00005.
5
Paying for statins.
BMJ. 2004 Feb 14;328(7436):400-2. doi: 10.1136/bmj.328.7436.400.
6
Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy.
Eur J Epidemiol. 2003;18(4):373-4. doi: 10.1023/a:1023723631518.
7
Treating the patient or the population? Part 1. Judging the benefit of treatment of individual patients.
West J Med. 2001 Jul;175(1):35-7. doi: 10.1136/ewjm.175.1.35.
本文引用的文献
1
Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.
BMJ. 2000 Oct 21;321(7267):983-6. doi: 10.1136/bmj.321.7267.983.
2
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
Am J Cardiol. 2000 Aug 1;86(3):257-62. doi: 10.1016/s0002-9149(00)00910-3.
3
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002.
4
What is the optimal age for starting lipid lowering treatment? A mathematical model.
BMJ. 2000 Apr 22;320(7242):1134-40. doi: 10.1136/bmj.320.7242.1134.
5
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.
BMJ. 2000 Mar 11;320(7236):671-6. doi: 10.1136/bmj.320.7236.671.
6
Guidelines on preventing cardiovascular disease in clinical practice.
BMJ. 2000 Mar 11;320(7236):659-61. doi: 10.1136/bmj.320.7236.659.
7
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.
J Gen Intern Med. 1999 Dec;14(12):711-7. doi: 10.1046/j.1525-1497.1999.02229.x.
8
Are drugs within a class interchangeable?
Lancet. 1999 Oct 2;354(9185):1202-4. doi: 10.1016/S0140-6736(99)03190-6.
9
Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults.
Am J Cardiol. 1998 Jul 1;82(1):61-5. doi: 10.1016/s0002-9149(98)00227-6.
10
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
Zotero 插件